Lexicon Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Lexicon Pharmaceuticals, Inc.‘s stocks are currently a part of 66 hedge funds’ portfolios, which represents 77.07% of the total amount of its stocks outstanding. This makes up a total of 112.25M shares of Lexicon Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -23.57% or -34.62M shares fewer. As for the holding position changes, 34.85% (23) of current hedge fund investors increased the number of shares held, 33.33% (22) of current holders sold a part of the shares held, and 7.58% (5) closed the holdings completely. 11 hedge funds are new holders of Lexicon Pharmaceuticals, Inc. stock in Q1 2023, it is 16.67% of total holders.
Hedge funds holding Lexicon Pharmaceuticals (Q2 2018 – Q1 2023)
| Q2 2018 | 119 |
|---|---|
| Q3 2018 | 116 |
| Q4 2018 | 118 |
| Q1 2019 | 115 |
| Q2 2019 | 106 |
| Q3 2019 | 99 |
| Q4 2019 | 112 |
| Q1 2020 | 106 |
| Q2 2020 | 103 |
| Q3 2020 | 86 |
| Q4 2020 | 103 |
| Q1 2021 | 104 |
| Q2 2021 | 106 |
| Q3 2021 | 96 |
| Q4 2021 | 109 |
| Q1 2022 | 100 |
| Q2 2022 | 85 |
| Q3 2022 | 96 |
| Q4 2022 | 100 |
| Q1 2023 | 66 |
Hedge funds changes in Lexicon Pharmaceuticals positions (Q2 2018 – Q1 2023)
| Q2 2018 | 12 | 45 | 37 | 15 | 10 |
|---|---|---|---|---|---|
| Q3 2018 | 12 | 34 | 42 | 14 | 14 |
| Q4 2018 | 18 | 30 | 43 | 16 | 11 |
| Q1 2019 | 15 | 38 | 32 | 18 | 12 |
| Q2 2019 | 10 | 29 | 33 | 17 | 17 |
| Q3 2019 | 17 | 22 | 28 | 23 | 9 |
| Q4 2019 | 25 | 32 | 31 | 12 | 12 |
| Q1 2020 | 21 | 36 | 26 | 24 | -1 |
| Q2 2020 | 19 | 38 | 23 | 22 | 1 |
| Q3 2020 | 4 | 30 | 25 | 22 | 5 |
| Q4 2020 | 30 | 25 | 31 | 13 | 4 |
| Q1 2021 | 27 | 30 | 27 | 24 | -4 |
| Q2 2021 | 24 | 40 | 26 | 21 | -5 |
| Q3 2021 | 8 | 33 | 36 | 18 | 1 |
| Q4 2021 | 23 | 38 | 29 | 11 | 8 |
| Q1 2022 | 7 | 32 | 39 | 16 | 6 |
| Q2 2022 | 5 | 30 | 30 | 17 | 3 |
| Q3 2022 | 19 | 38 | 22 | 10 | 7 |
| Q4 2022 | 11 | 38 | 31 | 6 | 14 |
| Q1 2023 | 11 | 23 | 22 | 5 | 5 |
Hedge funds changes in Lexicon Pharmaceuticals stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 4,863,000 | 1,924,000 |
|---|---|---|
| Q3 2018 | 3,325,000 | 3,018,000 |
| Q4 2018 | 640,000 | 1,766,000 |
| Q1 2019 | 1,359,000 | 4,902,000 |
| Q2 2019 | 939,000 | 2,724,000 |
| Q3 2019 | 1,292,000 | 1,118,000 |
| Q4 2019 | 1,744,000 | 752,000 |
| Q1 2020 | 293,000 | 164,000 |
| Q2 2020 | 258,000 | 114,000 |
| Q3 2020 | 288,000 | 146,000 |
| Q4 2020 | 2,261,000 | 1,100,000 |
| Q1 2021 | 2,577,000 | 1,115,000 |
| Q2 2021 | 2,833,000 | 974,000 |
| Q3 2021 | 1,304,000 | 283,000 |
| Q4 2021 | 462,000 | 486,000 |
| Q1 2022 | 169,000 | 58,000 |
| Q2 2022 | 475,000 | 77,000 |
| Q3 2022 | 287,000 | 54,000 |
| Q4 2022 | 295,637 | 58,064 |
| Q1 2023 | 16,562,000 | 0 |